1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 19 OCTOBER 2015

Cancer Drug News 19 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - China To Experience Increased Demand For Biotechnology Innovation Solutions
Industry Trend Analysis - Pfizer Entering Transformational Period
Industry Brief - Seattle Initiates Phase II Trial Of Adcetris Combination In r/r DLBCL
Industry Brief - Dako's Opdivo Companion Diagnostic FDA-Approved
Industry Brief - AstraZeneca/Peregrine Expand Immuno-Oncology Clinical Collaboration
Industry Brief - CASI's ENMD-2076 Receives EU Orphan Designation For HCC
Industry Brief - BTG/Mirada Collaborate Over Radioembolisation Therapy In Interventional Oncology
Industry Brief - Can-Fite's CF102 Gains EU Orphan Drug Designation For HCC
Industry Brief - Autotelic Acquires Worldwide Rights For Isarna's Trabedersen
Industry Brief - Incyte/Merck To Initiate Phase III Epacadostat/Keytruda Study In Melanoma
Industry Trend Analysis - BMS Proactively Defending Immuno-oncology Position
Industry Brief - Teikoku/Eagle Enter License Agreement for Alcohol-Free Docetaxel Formula
Industry Brief - 3SBio Licenses ALT-P7 From Alteogen In Chinese Markets
Industry Brief - Novartis Launches Affordable Medicines Portfolio In Kenya
Industry Trend Analysis - Daiichi's De-Diversification Efforts To Secure Long-Term Growth

Table Of Contents

Cancer Drug News 19 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.